“The reason the makers of over-the-counter oral cough and cold medicine for infants are withdrawing these medicines is that there have been rare patterns of misuse leading to overdose recently identified, particularly in infants,” said Linda A. Suydam, president of the trade association. "Safety is our top priority" Ms. Suydam added. “The F.D.A. should be first to act to ensure consumer safety rather than leaving families to rely on the industry itself,” Mr. Schumer said. Full Article at The New York Times